Uncategorized

Epicrispr gene silencer is 1st drug to boost muscle in form of muscular dystrophy, biotech says

Published

on

Epicrispr Biotechnologies has used its gene silencing tech to boost muscle mass in three patients with facioscapulohumeral muscular dystrophy, a clinical first for the debilitating disease with no approved treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version